|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
CTG006863523 |
003 |
DE-627 |
005 |
20230425171112.0 |
007 |
cr uuu---uuuuu |
008 |
210507s2022 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)CTG006863523
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)DRKS00013909
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)339/17
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Influence of Metabolic Profiles on Drug Safety in Routine Care
|b Influence of Metabolic Profiles on Drug Safety in Routine Care - EMPAR
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 06-07-2018, Last updated: 2022-11-24
|
650 |
|
4 |
|a Medical Condition: ;K27.0 - Peptic ulcer, site unspecified; Acute with haemorrhage;K27.1 - Peptic ulcer, site unspecified; Acute with perforation;K27.2 - Peptic ulcer, site unspecified; Acute with both haemorrhage and perforation;K27.4 - Peptic ulcer, site unspecified; Chronic or unspecified with haemorrhage;K27.5 - Peptic ulcer, site unspecified; Chronic or unspecified with perforation;K27.6 - Peptic ulcer, site unspecified; Chronic or unspecified with both haemorrhage and perforation;K28.0 - Gastrojejunal ulcer; Acute with haemorrhage;K28.1 - Gastrojejunal ulcer; Acute with perforation;K28.2 - Gastrojejunal ulcer; Acute with both haemorrhage and perforation;K28.4 - Gastrojejunal ulcer; Chronic or unspecified with haemorrhage;K28.5 - Gastrojejunal ulcer; Chronic or unspecified with perforation;K28.6 - Gastrojejunal ulcer; Chronic or unspecified with both haemorrhage and perforation;K29.0 - Acute haemorrhagic gastritis;K31.82 - [generalization K31.8: Other specified diseases of stomach and duodenum];K55.0 - Acute vascular disorders of intestine;K55.1 - Chronic vascular disorders of intestine;K55.22 - [generalization K55.2: Angiodysplasia of colon];K57.01 - [generalization K57.0: Diverticular disease of small intestine with perforation and abscess];K57.03 - [generalization K57.0: Diverticular disease of small intestine with perforation and abscess];K57.11 - [generalization K57.1: Diverticular disease of small intestine without perforation or abscess];K57.13 - [generalization K57.1: Diverticular disease of small intestine without perforation or abscess];K57.21 - [generalization K57.2: Diverticular disease of large intestine with perforation and abscess];K57.23 - [generalization K57.2: Diverticular disease of large intestine with perforation and abscess];K57.31 - [generalization K57.3: Diverticular disease of large intestine without perforation or abscess];K57.33 - [generalization K57.3: Diverticular disease of large intestine without perforation or abscess];K57.41 - [generalization K57.4: Diverticular disease of both small and large intestine with perforation and abscess];K57.43 - [generalization K57.4: Diverticular disease of both small and large intestine with perforation and abscess];K57.51 - [generalization K57.5: Diverticular disease of both small and large intestine without perforation or abscess];K57.53 - [generalization K57.5: Diverticular disease of both small and large intestine without perforation or abscess];K57.81 - [generalization K57.8: Diverticular disease of intestine, part unspecified, with perforation and abscess];K57.83 - [generalization K57.8: Diverticular disease of intestine, part unspecified, with perforation and abscess];K57.91 - [generalization K57.9: Diverticular disease of intestine, part unspecified, without perforation or abscess];K57.93 - [generalization K57.9: Diverticular disease of intestine, part unspecified, without perforation or abscess];K62.5 - Haemorrhage of anus and rectum;K66.1 - Haemoperitoneum;K76.3 - Infarction of liver;K92.0 - Haematemesis;K92.1 - Melaena;K92.2 - Gastrointestinal haemorrhage, unspecified;M25.0 - Haemarthrosis;M31.1 - Thrombotic microangiopathy;M62.2 - Ischaemic infarction of muscle;N02 - Recurrent and persistent haematuria;R04 - Haemorrhage from respiratory passages;R23.3 - Spontaneous ecchymoses;R31 - Unspecified haematuria;R57.1 - Hypovolaemic shock;R58 - Haemorrhage, not elsewhere classified;S06.33 - [generalization S06.3: Focal brain injury];S06.34 - [generalization S06.3: Focal brain injury];S06.4 - Epidural haemorrhage;S06.5 - Traumatic subdural haemorrhage;S06.6 - Traumatic subarachnoid haemorrhage;S06.8 - Other intracranial injuries;S26.0 - Injury of heart with haemopericardium;S27.1 - Traumatic haemothorax;S27.31 - [generalization S27.3: Other injuries of lung];S36.01 - [generalization S36.0: Injury of spleen];S36.11 - [generalization S36.1: Injury of liver or gallbladder];S36.81 - [generalization S36.8: Injury of other intra-abdominal organs];T00.9 - Multiple superficial injuries, unspecified;T45.5 - Poisoning: Anticoagulants;T79.2 - Traumatic secondary and recurrent haemorrhage;T79.4 - Traumatic shock;Y57 - Other and unspecified drugs and medicaments;M60.1 - Interstitial myositis;M60.8 - Other myositis;M60.9 - Myositis, unspecified;G72.0 - Drug-induced myopathy;M62.8 - Other specified disorders of muscle;M62.9 - Disorder of muscle, unspecified;M79.1 - Myalgia;M79.7 - Fibromyalgia;D62 - Acute posthaemorrhagic anaemia;D65.1 - [generalization D65: Disseminated intravascular coagulation [defibrination syndrome]];D68.33 - [generalization D68.3: Haemorrhagic disorder due to circulating anticoagulants];D50.0 - Iron deficiency anaemia secondary to blood loss (chronic);Y57.9 - Drug or medicament, unspecified;D68.35 - [generalization D68.3: Haemorrhagic disorder due to circulating anticoagulants];K25.2 - Gastric ulcer; Acute with both haemorrhage and perforation;K25.4 - Gastric ulcer; Chronic or unspecified with haemorrhage;K25.5 - Gastric ulcer; Chronic or unspecified with perforation;K25.6 - Gastric ulcer; Chronic or unspecified with both haemorrhage and perforation;D69.80 - [generalization D69.8: Other specified haemorrhagic conditions];D69.9 - Haemorrhagic condition, unspecified;G45 - Transient cerebral ischaemic attacks and related syndromes;G95.1 - Vascular myelopathies;H11.3 - Conjunctival haemorrhage;H21.0 - Hyphaema;H31.3 - Choroidal haemorrhage and rupture;H34.0 - Transient retinal artery occlusion;H34.1 - Central retinal artery occlusion;H34.2 - Other retinal artery occlusions;H34.8 - Other retinal vascular occlusions;H34.9 - Retinal vascular occlusion, unspecified;H35.6 - Retinal haemorrhage;H43.1 - Vitreous haemorrhage;H45.0 - Vitreous haemorrhage in diseases classified elsewhere;H92.2 - Otorrhagia;I21 - Acute myocardial infarction;I22 - Subsequent myocardial infarction;I23 - Certain current complications following acute myocardial infarction;I24 - Other acute ischaemic heart diseases;I25 - Chronic ischaemic heart disease;I26 - Pulmonary embolism;I60 - Subarachnoid haemorrhage;I61 - Intracerebral haemorrhage;I62 - Other nontraumatic intracranial haemorrhage;I63 - Cerebral infarction;I64 - Stroke, not specified as haemorrhage or infarction;I65 - Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;I66 - Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction;I71 - Aortic aneurysm and dissection;I72 - Other aneurysm and dissection;I74 - Arterial embolism and thrombosis;I79.0 - Aneurysm of aorta in diseases classified elsewhere;I80 - Phlebitis and thrombophlebitis;I81 - Portal vein thrombosis;I82 - Other venous embolism and thrombosis;I85.0 - Oesophageal varices with bleeding;I87.0 - Postthrombotic syndrome;J94.2 - Haemothorax;K26.0 - Duodenal ulcer; Acute with haemorrhage;K26.1 - Duodenal ulcer; Acute with perforation;K26.2 - Duodenal ulcer; Acute with both haemorrhage and perforation;K26.4 - Duodenal ulcer; Chronic or unspecified with haemorrhage;K26.5 - Duodenal ulcer; Chronic or unspecified with perforation;K26.6 - Duodenal ulcer; Chronic or unspecified with both haemorrhage and perforation;K25.0 - Gastric ulcer; Acute with haemorrhage;K25.1 - Gastric ulcer; Acute with perforation
|
650 |
|
4 |
|a Study Type: Observational
|
650 |
|
4 |
|a Recruitment Status: Complete: follow-up complete
|
650 |
|
4 |
|a 610
|
773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2022) vom: 14. Nov.
|
773 |
1 |
8 |
|g year:2022
|g day:14
|g month:11
|
856 |
4 |
0 |
|u http://www.drks.de/DRKS00013909
|z kostenfrei
|3 Volltext
|
912 |
|
|
|a GBV_CTG
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a AR
|
952 |
|
|
|j 2022
|b 14
|c 11
|